IPO - Truscreen Group Limited, page-13

Celts / others
I have been following and already own Truscreen shares in NZ, TRU has been listed on the New Zealand stock exchange for a few years, it has made good progress during that time, (it already has many customers and growing distribution of its products - have a look at its Website and past announcements).
although it is listed in NZ, all of its operations are in Australia, the reason being I understand is that listing and compliance requirements for new companies are better in NZ.
And yes as far as your question about Truscreen being in Au already in the past, I understand that yes it did start in Australia.

On their website they say:

TruScreen’s development was led by leading medical academics from Sydney University who sought to establish objective technology that could improve on the conventional Pap test. They believed that it should be possible to distinguish between normal and abnormal tissue by measuring changes in physical properties, such as electrical potential.

TruScreen’s development was led by leading medical academics from Sydney University.

Professor Coppleson, an international leader in colposcopy and cervical cancer, sought to establish objective technology that could improve on the conventional Pap test, which has limitations in population-based screening due to its subjective nature and its need for laboratory facilities and qualified personnel. Dr. Reid believed that it should be possible to distinguish between normal and abnormal tissue by measuring changes in physical properties, such as electrical potential.

After extensive and intensive R&D, the TruScreen ‘Opto Electrical’ Technology for the detection of cancerous cells was developed. The TruScreen Cervical Cancer Screening System is built on this technology and comprises a unique medical device, algorithm technology and processes designed to detect the presence, at the time of screening, of pre-cancerous and cancerous tissue on the cervix.

Following the restructuring of the business, TruScreen Pty Ltd, a subsidiary company of TruScreen Group Ltd (NZ), was formed in October 2013 to hold all TruScreen assets, including IP, and to act as the heart of the operation of the TruScreen business. The board and executive team combine experience and commercial ideas and strategies which we believe are both essential to and sufficient for the success of TruScreen globally.

In 2016, the TruScreen2 second-generation device was launched. This encapsulates world-class medical technology and contains many new and unique features including a massively increased processing capacity and faster processing, improved performance and improved user experience.

The TruScreen technology is at the forefront of the development of objective opto-electric tissue differentiation and it enjoys significant intellectual property protection.

best regards to all
from fp